StockData
Rocket Pharmaceuticals, Inc. logo

Rocket Pharmaceuticals, Inc. (RCKT) stock

RCKTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 3/30
$2.11+0.00 (0.00%)

Close on Nov 18, 2026Market cap $231.62MP/E –Yield –

Rocket Pharmaceuticals price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Rocket Pharmaceuticals's price to book ratio was 0.7× on Nov 11, 2026, against 1.2× a year earlier. Over the last 5 years it ranged from 0.6× to 5.4×, with a median of 2.7×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.7×−0.5
2025Dec 31, 20251.2×−2.3
2024Dec 31, 20243.5×−1.5
2023Dec 29, 20235.0×+1.4
2022Dec 30, 20223.6×+0.7
2021Dec 31, 20212.9×−9.6
2020Dec 31, 202012.5×+7.9
2019Dec 31, 20194.6×+0.5
2018Dec 31, 20184.1×+2.7
2017Dec 29, 20171.4×−0.5
2016Dec 30, 20161.9×−0.6
2015Dec 31, 20152.6×–

More Rocket Pharmaceuticals figures

See a number that looks wrong?